MD678G2 - DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective - Google Patents

DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective

Info

Publication number
MD678G2
MD678G2 MD96-0167A MD960167A MD678G2 MD 678 G2 MD678 G2 MD 678G2 MD 960167 A MD960167 A MD 960167A MD 678 G2 MD678 G2 MD 678G2
Authority
MD
Moldova
Prior art keywords
selective
oxobenzalhydrazinecopper
dihydrate
oxo
antimicrobic
Prior art date
Application number
MD96-0167A
Other languages
English (en)
Russian (ru)
Other versions
MD678F1 (ro
Inventor
Нина САМУСИ
Виорел ПРИСАКАРЬ
Виктор ЦАПКОВ
Светлана БУРАЧЕВА
Original Assignee
Государственный Университет Молд0
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Университет Молд0, Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Университет Молд0
Priority to MD96-0167A priority Critical patent/MD678G2/ro
Publication of MD678F1 publication Critical patent/MD678F1/ro
Publication of MD678G2 publication Critical patent/MD678G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Invenţia se referă la substanţele biologic active din clasa compuşilor coordinativi ai metalelor de tranziţie cu hidrazoni şi poate fi aplicată în medicină şi microbiologie la crearea mediilor nutritive selective.Esenţa invenţiei constă în obţinerea unui nou compus coordinativ biologic activ şi anume di(m-O)-di[N-(2-oxo-1-naftal)-N′-a-oxobenzalhidrazincupru] dihidrat, care posedă proprietăţi antimicrobiene selective.Rezultatul tehnic al invenţiei constă în aceea că activitatea antimicrobiană a complexului declarat faţă de bacteriile din genul Staphylococcus creşte în comparaţie cu cel mai apropiat analog cel puţin de 129 ori, iar faţă de Escherihia coli rămâne la acelaşi nivel.
MD96-0167A 1996-07-17 1996-07-17 DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective MD678G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD96-0167A MD678G2 (ro) 1996-07-17 1996-07-17 DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD96-0167A MD678G2 (ro) 1996-07-17 1996-07-17 DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective

Publications (2)

Publication Number Publication Date
MD678F1 MD678F1 (ro) 1997-02-28
MD678G2 true MD678G2 (ro) 1997-09-30

Family

ID=19738875

Family Applications (1)

Application Number Title Priority Date Filing Date
MD96-0167A MD678G2 (ro) 1996-07-17 1996-07-17 DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective

Country Status (1)

Country Link
MD (1) MD678G2 (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4174C1 (ro) * 2011-10-25 2013-01-31 Институт Химии Академии Наук Молдовы Derivaţi tiosemicarbazonici ai acidului 4-formil-3-hidroxi-2-naftoic cu proprietăţi antibacteriene

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
М.Д.Машковский. "Лекарственные средства", т. 2, 1987 г.,"Беларусь", Минск, с. 264-265. *
Таркоджиель Мианперем. "Координационные соединения 3d-элементов с некоторыми гидразонами и азинами". 1991 г., Дис. канд. хим. наук, Кишинев, с.163. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4174C1 (ro) * 2011-10-25 2013-01-31 Институт Химии Академии Наук Молдовы Derivaţi tiosemicarbazonici ai acidului 4-formil-3-hidroxi-2-naftoic cu proprietăţi antibacteriene

Also Published As

Publication number Publication date
MD678F1 (ro) 1997-02-28

Similar Documents

Publication Publication Date Title
EP0555618A3 (en) Dietetic and/or pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
AU3506893A (en) Use of fullerenes in diagnostic and/or therapeutic agents
DK1005353T3 (da) Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
FI964681L (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
ATE166105T1 (de) Bacillus bakterium und dessen verwendung
HUP0100786A3 (en) Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
ATE207755T1 (de) Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
EP0675708A1 (en) PHARMACEUTICAL AND DERMOCOSMETIC AGENTS CONTAINING HORSE DECOLOSTRUM.
WO1997040072A3 (en) Adam proteins and uses thereof
ATE107660T1 (de) Therapeutisches mittel.
HU9401260D0 (en) Fema gene of staphylococcus epidermis, fema protein, and vectors and microorganisms comprising the fema gene
GR871488B (en) New antibiotics
EP0652285A3 (en) Lactic acid bacteria and fermented milk product.
MY140870A (en) Nutrition supplement containing lactobacillus acidophilus, yeast and soy protein
Ijong et al. Microflora and chemical assessment of an Indonesian traditional fermented fish sauce" Bakasang"
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
MD678G2 (ro) DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective
GB9424661D0 (en) Enzymes, microorganisms and their use
DE59808313D1 (de) Verwendung von wirkstoffkombinationen aus antibiotika und terpenhaltigen pflanzenextrakten in der tiermedizin
Hamann Enhancement of tyrosinase stability by immobilization on nylon 66
IT1312090B1 (it) Microrganismi inattivati comprendenti sostanze solubili e/osolubilizzabili ad attivita' farmacologica e/o sostanze nutrizionali
IL113544A0 (en) Active peptide and its preparation
Cotton Atovaquone (Mepron) suspension approved by FDA. Food and Drug Administration
DE69830371D1 (de) Inaktivierte Mikroorganismen, welche Mineralien enthalten, deren Herstellung und Verwendung in Lebensmitteln, pharmazeutische und zootechnische Zusammensetzungen

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20160717